PTC Therapeutics Q1 2019 Earnings Report

Total Revenue
$53.6M
Previous year: $56.1M
-4.4%
EPS
-$1.29
Previous year: -$0.46
+180.4%
R&D Expenses
$52.6M
SG&A Expenses
$40.5M
Net Loss
$72.1M

PTC Therapeutics

PTC Therapeutics

PTC Therapeutics Revenue by Segment